Earnings dates and session timing shown here are aggregated from third-party sources, are frequently estimated, and are subject to change or confirmation by the reporting company. Nothing on this site is financial advice.
Sight Sciences Inc. (SGHT) is an innovative medical technology company specializing in the advancement of treatments for ocular diseases, with a particular emphasis on glaucoma management through both surgical and non-surgical approaches. The company’s diverse product portfolio, supported by a robust intellectual property framework, positions it favorably as demand for minimally invasive ophthalmic therapies escalates. By focusing on enhancing patient outcomes and refining its distribution network, Sight Sciences is set to capture significant market share in the evolving healthcare landscape, making it a noteworthy opportunity for institutional investors seeking growth in the medical technology sector.
Quotes and fundamental data are delayed and provided for informational purposes only — nothing on this page is financial advice. Figures are as reported by the company and its data providers and may be revised. Estimates reflect analyst consensus at the time of each report.
$8.01
| Quarter | EPS | Revenue | Price move | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Est | Adj | Result | GAAP | Est | Actual | Surprise | 1D Pre | On-Day | 1D Post | |
Q ended Jun 30, 2026 Reported Aug 5, 2026 | $-0.15 | $-0.08 | Beat +46.7% | $-0.08 | $21.69M | $23.39M | +7.8% | 1D Pre+2.0% | On-Day-1.6% | 1D Post+27.7% |
Q ended Mar 31, 2026 Reported May 6, 2026 | $-0.20 | $-0.24 | Miss -20.0% | $-0.24 | $18.55M | $19.7M | +6.2% | 1D Pre+2.6% | On-Day-0.7% | 1D Post+23.0% |
Q ended Dec 31, 2025 Reported Mar 4, 2026 | $-0.15 | $-0.08 | ||||||||
Dashed outlines show the analyst consensus estimate for periods where one was published. Hover or tap a bar for exact figures. Values as reported; not adjusted for splits after the report date.
| — |
| $20.34M |
| $20.39M |
| +0.2% |
| 1D Pre-6.4% |
| On-Day+2.9% |
| 1D Post-26.8% |
Q ended Sep 30, 2025 Reported Nov 6, 2025 | $-0.26 | $-0.16 | Beat +38.5% | — | $17.74M | $19.91M | +12.2% | 1D Pre+1.0% | On-Day-0.6% | 1D Post+16.4% |